Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 1: Thiazide diuretics

CMAJ. Canadian Medical Association Journal

Volumn 163, Issue 1, 2000, Pages 57-60

  Wright, James M ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDACTAZINE; AMILORIDE; AMILORIDE PLUS HYDROCHLOROTHIAZIDE; BENDROFLUMETHIAZIDE; BUMETANIDE; CHLORTALIDONE; ETACRYNIC ACID; FUROSEMIDE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; INDAPAMIDE; LOZIDE; METOLAZONE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TORASEMIDE; TRIAMTERENE;

BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DIURESIS; DRUG COST; DRUG EFFICACY; DRUG TOLERABILITY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0034636759     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. 1. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke and coronary heart disease. Part 2: Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
2. 2. Mulrow C, Lau J, Cornell J, Brand M, Amato M. Antihypertensive drug therapy in the elderly [Cochrane review]. In: Gueyffier F, Lau J, Mulrow CD, editors. Hypertension module of the Cochrane Database of Systematic Reviews [updated 1997 June 3]. In: The Cochrane Library; Issue 2, 2000. Oxford: Update Software.
3. 3. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997;277: 739-45.
4. 4. Wright JM, Lee CH, Chambers GK. Systematic review of antihypertensive therapies: Does the evidence assist in choosing a first-line drug? CMAJ 1999;161:25-32. Available: www.cma.ca/cmaj/vol-161/issue-1/0025.htm
5. 5. Materson BJ, Reda DJ, Cushman WC, Massic BM, Freis ED, Kochar MS, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993;328:914-21.
6. 6. Neaton JD, Grimm RH Jr, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al, for the Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study. Final results. JAMA 1993;270:713-24.
7. 7. Philipp T, Anlauf M, Distler A, Holzgreve H, Michaelis J, Wellek S. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group. BMJ 1997;315:154-9.
8. 8. Schmiedet RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA 1996;275:1507-13.
9. 9. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
10. 10. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996;276:1886-92.